News for Healthier Living

ADC Combination Outperforms Standard Treatment of Advanced Triple-Negative Breast Cancer

Dana-Farber Cancer Institute presents potentially practice changing results from the phase 3 ASCENT-04/KEYNOTE-D19 clinical trial at American Society of Clinical Oncology (ASCO) annual meeting

May 31, 2025


June 14 2025

June 13 2025

June 12 2025

June 11 2025

June 10 2025

June 9 2025

June 8 2025

June 7 2025

June 6 2025

June 5 2025

June 4 2025

June 3 2025

June 2 2025

June 1 2025